Bought some $HIMS in this spike. It’s partnering with $NVO.Hims & Hers Health, Inc. Class ANYSE:HIMSSwing_Trader_SaanBought some HIMS on this after hours spike yesterday. The company is partnering with Novo Nordisk to offer obesity drugs through its telehealth platform. That could significantly expand access to blockbuster GLP-1 treatments like Wegovy, one of the fastest-growing drug categories in healthcare. The obesity drug market is expected to become one of the largest in healthcare over the next decade, and HIMS could benefit by acting as the digital distribution layer connecting patients directly to these treatments.